The findings of a new study indicate erectile dysfunction and inflammation could be prevented by blocking the effect of endothelin-1, which is a potent vasoconstrictor peptide and regulator of blood flow. A research team from Aarhus University in Denmark will present its findings virtually October 4–7 at the Seventeenth International Conference on Endothelin (ET-17), hosted and organized by the American Physiological Society (APS).